Showing results (891-900 of 942) with videos related to
Sort By:
Pageof 95
Blood|March 6, 2024
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia miceAsim Saha, Rahul Palchaudhuri, Leanne Lanieri, et al.Blood|August 17, 2019
Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomesStosh Ozog, Nina D Timberlake, Kip Hermann, et al.The Journal of Clinical Investigation|April 1, 2024
Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centersKarsten Eichholz, Yoshinori Fukazawa, Christopher W Peterson, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|September 22, 2025
May Measurement Month 2022: an analysis of blood pressure screening results from VietnamMinh Huynh Van, Viet Nguyen Lan, Huy Nguyen Vu Quoc, et al.British Journal of Sports Medicine|June 8, 2022
Arthroscopic partial meniscectomy versus physical therapy for traumatic meniscal tears in a young study population: a randomised controlled trialSabine J A van der Graaff, Susanne M Eijgenraam, Duncan E Meuffels, et al.Cancers|March 13, 2024
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived XenograftsFaizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, et al.Proceedings. Biological Sciences|January 27, 2026
Infectious disease outbreak controllability: biological, social and public health factorsRobin N Thompson, Shweta Bansal, Hannah Clapham, et al.Arthritis Care & Research|May 11, 2019
Real-World Effectiveness of Common Treatment Strategies for Juvenile Idiopathic Arthritis: Results From a Canadian CohortAmieleena Chhabra, Kiem Oen, Adam M Huber, et al.Blood Advances|October 30, 2023
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphomaAlexandre V Hirayama, Erik L Kimble, Jocelyn H Wright, et al.Molecular Therapy. Advances|May 15, 2026
<i>In vivo</i> HSC gene therapy enables sustained eCD4-Ig expression for SIV preventionChang Li, Anna K Anderson, Anne-Sophie Kuhlmann, et al.Pageof 95